INTRODUCTION

Imaging Angiogenesis
Once avascular tumor volumes reach approximately 1-2 mm 3 further growth is no longer supported by passive diffusion of nutrients, but requires the recruitment of new vasculature to the tumor mass (1) . The recruitment of new vasculature, or angiogenesis, is a believed to be a characteristic trait of nearly all malignant cancers (2) . Angiogenesis in a non-pathological state typically results in the formation of normal vasculature, hierarchically organized from large (arteries) to small (capillaries), whereas in pathological states the resulting vasculature is often fragile, leaky, poorly organized, and contains incomplete vessel connections (3) . The differences between healthy and abnormal vasculature is one aspect that can be investigated through magnetic resonance imaging (MRI).
Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) is an
imaging technique that can be used to investigate vascular properties of tumors including, for example, blood vessel perfusion and permeability, blood volume, and the extravascular extracellular volume fraction. DCE-MRI probes these characteristics through analysis of dynamic voxel or region of interest (ROI) signal-intensity curves obtained before, during, and after injection of a paramagnetic contrast agent (CA) such as gadopentetate dimeglumine, Gd-DTPA, (Magnevist, Wayne NJ). In healthy vasculature
Gd-DTPA predominantly remains within the vessel and is cleared by the kidneys.
However, in abnormal vasculature with highly permeable vessel walls, it leaks into the surrounding tissue space. As the CA travels through the vasculature and extravasates into tissue, the local T 1 , T 2 , and T 2 * are shortened, to a degree depending on the local concentration of CA thereby resulting in a change in the measured signal-intensity. Time dependent variations of the signal-intensity curve are related to local physiological properties (e.g., vessel wall permeability, blood flow, blood volume, and extravascular space) which can be investigated through pharmacokinetic modeling (4) making it a valuable tool in preclinical and clinical studies of, for example, anti-angiogenic treatments (5) .
DCE-MRI data can be analyzed qualitatively, for example, observing tissue enhancement after CA injection to delineate tumor tissue from normal tissue, or quantitatively to extract values describing CA uptake or tumor characteristics. One class of semi-quantitative approaches that does not require modeling of CA kinetics are measures such as wash-in rate and the initial area under the curve (iAUC). The wash-in rate is defined as the maximum slope between injection of the CA and the peak CA intensity, and has been used to distinguish the early enhancement of tumor tissue from healthy tissue (6) . Similarly, iAUC measurements have been used to monitor response to anti-angiogenic therapies (7); however, the exact physiological meaning of iAUC remains unclear (8, 9) . Both wash-in rate and iAUC describe heterogeneity of CA uptake and are a mixed measurement of blood flow, vessel permeability, and interstitial space (9) . Individual components of a tumor's vasculature system (e.g., blood flow) can be examined individually through pharmacokinetic modeling of the CA. These pharmacokinetic models describe the uptake, distribution, and clearance of the injected CA within the body allowing parameters describing the vasculature and tumor environment to be assessed.
Components of Quantitative DCE-MRI
In order to perform quantitative DCE-MRI, three data sets are required of the tissue under investigation: 1) a pre-contrast T 1 map, 2) serial T 1 -weighted images obtained before, during, and after the injection of a paramagnetic CA, and 3) the time rate of change of the concentration of CA in a nearby feeding vessel, the so-called vascular input function (VIF). An example VIF, shown in Figure 1 , consists of a three distinct characteristics, the rapid wash-in (labeled in the figure as -a‖), the peak CA concentration in the plasma (b), and the washout (c), that need to be estimated to describe CA kinetics in blood.
Figure 1:
An example VIF acquired from the linguofacial artery in a rat. Following injection of a bolus of a CA, C p rapidly increases (a), reaches its peak (b) concentration during the first pass, and subsequently decreases (c) due to distribution and elimination. Point (a) represents the rapid wash-in of a bolus of CA Capturing both the rapid wash-in and the peak concentration require high temporal resolution sampling. The washout portion, however, can be characterized with lower temporal resolution sampling. Accurately estimating these distinct parts in a VIF is extremely challenging, particularly in small animals where small vessel sizes impedes direct VIF measurement.
Measuring the Vascular Input Function
In general, there are three main ways to acquire the VIF: 1) through arterial blood sampling (10), 2) assuming a functional form (e.g., bi-exponential decay) of the VIF (11), and 3) directly from a vessel visible in the imaging data (11) (12) (13) . Arterial blood sampling is considered the -gold standard‖ as it allows direct measurement of the CA concentration. However in small animals where the total blood volume is about 2 mL for mice and 16 mL for rats (14) , blood sampling is both limited by the number of samples that can be acquired and the achievable temporal resolution. One study by Wedeking et al (15) characterizing the plasma distribution of Gd-DTPA in rats acquired 22 samples over 90 minutes. After injection with the CA, the initial rapid rise was sampled every 30-seconds followed by samples spaced 1-minute, 10-minutes, and 15-minutes apart during the washout portion. This study showed that after the CA concentration reaches its peak in the blood its washout can be described by bi-exponential decay. A later study by Nagaraja et al (10) in rats compared MRI-measured VIFs to blood sampled VIFs. The MRI-measured VIF was selected from venous blood in the superior sagittal sinus, whereas after the MRI examination the blood sampled VIF was collected from the femoral artery following a second injection of the CA. This study improved the temporal resolution for the arterial blood sampling by characterizing the rapid rise of CA every 5-seconds and the washout of the CA every 60-seconds, but required blood sampling after the DCE-MRI acquisition. Alternatively, assuming a functional form of the VIF can provide a well characterized and a high signal-to-noise ratio (SNR) curve. A functional form can be generated through fitting a model describing CA kinetics to a VIF acquired through (for example) arterial blood sampling or direct imaging of blood vessels. One common form describes CA washout through bi-exponential decay (15), a modification of which includes two linear fits describing the rapid rise of the CA prior to the peak (16) .
In this application, the two exponentials refer to the distribution of the CA between compartments and the elimination of CA in the compartments by the kidneys (17) .
Functional descriptions of the VIF allow high SNR VIFs to be disseminated through publication or generated from low SNR data. An early example using a functional form of the VIF is in Tofts et al (17) , where VIF data from the literature (18) was fit to a biexponential decay and used to characterize CA concentration in plasma. Another functional form derived from an average of a cohort of VIFs consists of a combination of a Gaussian and an exponential modulated by a sigmoid (19) . Similar to the biexponential decay models it characterizes the rapid rise, peak concentration, and washout; however, this new form allows the recirculation of the CA to be characterized and included in the washout phase. The VIF may also be acquired directly from the imaging data if a well-resolved blood pool from a feeding vessel is present within the field of view (FOV). One approach is to include either the heart or a major artery within the field of view (11, 20) . This can be challenging in small animals where small vessel sizes make it difficult to select blood All of these image-based approaches, however, require high temporal resolution acquisitions to capture the VIF's rapid uptake and washout of the CA. Conversely in tissue, CA uptake and washout can be accurately characterized at a lower temporal resolution. Additionally, in pre-clinical cancer studies high spatial resolution is desired to observe tumor heterogeneity. Tumors do not consist of just a single tissue type but consist of multiple tissue types resulting in a range of tumor properties (22, 23) . These image-based approaches therefore require a technical balance between high spatial and temporal resolution acquisitions in order to characterize both tumor heterogeneity and the VIF.
Population-Averaged VIF
Two alternative imaging derived approaches that alleviate the technical constraints of acquiring both high spatial and temporal resolution images are the reference region method and the use of a population-averaged VIF. In a reference region analysis, parameters and the signal-intensity time course from a reference tissue are used in pharmacokinetic analysis to calibrate CA uptake in tumors (24) . This allows the high temporal resolution acquisition required to characterize the VIF to be replaced by a reference tissue whose CA uptake and washout can be characterized at a lower temporal resolution. Rather than acquire a VIF for each individual subject, some investigators have explored using a population-averaged VIF built from a cohort of subjects and subsequently used for pharmacokinetic analysis (11, 19, (25) (26) (27) (28) . Exchanging an individual based VIF with a population-averaged VIF reduces the considerable temporal resolution and SNR restrictions required for individual VIF measurements, thereby potentially allowing improved characterization of the tumor environment. An early investigation by
Simpson et al (29) in rats on the optimization of VIF acquisition suggested the use of a population-averaged VIF for measuring perfusion. The population-averaged VIF resulted in errors up to 60% when a common dose was used for each rat; however, when rats were injected with a dose proportional to their mass these errors dropped to 20%. These observed errors in perfusion estimates may arise from both experimental (e.g., anesthetic agent, duration of anesthesia, dose per mass) and physiological (e.g., disease state, blood pressure, heart rate) variations between the individual and the cohort. A study by Pickup et al (30) in mice preferred the use of an individual VIF over the population-averaged VIF due to considerable inter-animal variability in the VIF resulting in inconsistencies between parameters derived from both VIFs. (It should be noted, however, that this study included only four mice in the data set.) Contrary to these two studies, Parker et al (19) generated a population-averaged VIF from 23 patients (ages ranging from 18-80 years)
with advanced cancer and demonstrated that a high-temporal-resolution population VIF had increased sensitivity to therapy induced changes. Following this McGrath et al (11) compared (in rats) the repeatability and sensitivity of pharmacokinetic parameters more recent study with rats investigated the effect of heart rate on pharmacokinetic parameters extracted using a population-averaged VIF from DCE-CT to those extracted through a reference-region approach (26) . No significant difference was observed between the population-averaged VIF and reference region approaches for rats with the same heart rate; however, when heart rate was increased by 30% a 19-43% difference was observed between reference region and the population-averaged VIF. Most recently, a study by Loveless et al (27) , compared the VIF in mice using two different CAs of varying molecular weight and reported very high correlation (concordance correlation coefficient > 0.850) for K trans parameters estimated using population and individual VIFs with Gd-DTPA.
Following the work of Loveless et al (27) , the goal of this study is to perform a careful comparison between individual and population-averaged VIFs derived from a cohort of rats bearing brain tumors. The individual and population based VIFs were used to extract physiologically relevant parameters through DCE-MRI modeling and the resulting parameters were statistically compared at both the voxel and ROI level.
CHAPTER II EXPERIMENTAL METHODS
Pharmacokinetic Modeling Theory
Pharmacokinetic modeling is a quantitative tool that can be used in the analysis of It is straight forward to write down the relevant differential equation describing this situation:
[1]
In words, Eq. 
Not included in the model displayed in Figure 2 is the effect of a significant 
In order to use the Toft's model in Eq. [2] and its extension presented in Eq. [3] , to extract pharmacokinetic parameters a T 1 map, a set of T 1 -weighted images before, during, and after injection with a CA, and knowledge of the CA kinetics in blood is 
Ideally T 1 maps (≡ 1/R 10 ) would be acquired at each time point, however, T 1 changes too rapidly for this approach to be feasible. Instead a baseline T 1 map is acquired to calibrate future changes as observed in the set of serial T 1 -weighted images. Using a spoiled gradient echo sequence a R 1 time course can be extracted from a signal-intensity curve via Eqs. [7] and [8] :
where TR and α are scan parameters, S 0 was defined as   [8] where S pc is the pre-contrast signal intensity. By extracting dynamic signal intensity data of voxel or ROI within tumor tissue C t can be determined using Eqs. [5, [7] [8] and using the VIF C p can be determined using Eqs. [6] [7] [8] .
In this work, both the standard (ST) model, Eq. [2] , and the extended (EX) model, Eq. [3] , are used in evaluating DCE-MRI data sets. These models provide insight into 
DCE-MRI
While imaging procedures are described in more detail elsewhere (12), we briefly present the salient features. MRI was performed using a 9.4 T horizontal-bore magnet (Agilent, Santa Clara, CA, USA). A pre-contrast map of T 1 (i.e., T 10 ) was generated with data from an inversion-recovery snapshot experiment-repetition time ( 
Data Analysis
For each animal, the pre-contrast T 1 map was used to identify the tumor ROI from which an R 1 tissue time course was extracted for each voxel. This R 1 tissue time course is then related to C t via Eq. [5] , where R 10 ≡ 1/T 10 , and r 1 was assigned 3.8 mM -1 s -1 (32) . A (conservative) five to ten voxel ROI was then manually drawn around the linguofacial artery in the neck from which voxels exhibiting partial volume effects were eliminated by visual inspection and the remaining voxels were averaged to form the VIF. Using a model of fast water exchange (33) across red blood cell membranes, the R 1 time course of the VIF was converted to C p via Eq. [6] , where blood R 10 was assigned 0.435s -1 (34) and h was set to 0.46. After aligning the arrival times of the individual VIFs (VIF ind ), the mean of seven of the eight VIF ind was used to create the population-averaged VIF (VIF pop ). Rat number two was excluded from the VIF pop calculation for having a VIF ind outside of one standard deviation from the calculated mean. Errors introduced by inflow effects were minimized through an iterative process based on the approach by Li et al (20) . Briefly, each animal's VIF ind and VIF pop were scaled so that the concentration time course of a 50 voxel ROI in the temporalis muscle yielded a v e of 0.11 (20, 35, 36) . The scaled VIF ind and VIF pop for each animal were used with the C t time courses from the tumor to extract K trans , v e , and v p via both the ST and EX models through a non-linear fitting constrained to non-negative values in MATLAB R2012a (Natick, MA, USA).
Additionally, the VIF pop was then fit to Eq. [9] to generate a functional form of the VIF used in this study:
where the summation of a 1 and a 2 refer to the amplitude of the first pass of CA and m 1 and m 2 refer to decay constants describing the washout of CA due to exchange with compartments and clearance through kidneys, respectively.
After fitting the voxel data to the ST and EX models the coefficient of determination, r 2 , was calculated to measure the closeness of fit to the voxel data. Voxel fits with a returned r 2 < 0.6, or estimated parameters outside a physiologically relevant range (0 < K trans < 1 min -1 , 0 < v e < 1, and 0 < v p < 1) were removed from subsequent analyses.
Statistical Analysis
Agreement between pharmacokinetic parameters determined by fitting C t to the 
where σ pop and µ pop are the standard deviation and mean for a given parameter (e.g., 
CHAPTER III RESULTS
Population-averaged VIF
The population-averaged VIF is presented in Figure 4a The inset in Figure 4b shows the population and individual based ΔR 1 (≡ R 1b (t)-R 10 ) and .
ROI Analysis
The results of ROI analysis are presented in Figure 5a and Table 1 . Similarly, CCC provides a measurement of the absolute agreement between parameters estimated using VIF pop and VIF ind , and may assume a value between 0 and 1. A CCC 
Voxel Analysis
The estimated parameters obtained by fitting the voxel level C t time courses to the ST and EX models with both VIF ind and VIF pop were compared across all animals. Panel Likewise for intercept results, 10 of the 16 ST parameters and 14 of the 16 EX parameters had intercepts significantly different from zero (P < 0.05). Of the 25 slopes which were significantly different from zero, 11 were from overestimation of K trans in fits using VIF pop and seven were from underestimation of v e in fits using VIF pop . The high level of agreement observed in panels (b)-(f) of Figure 5 is quantified in Table 4 by the CCC and its 95% confidence interval. Visually, and confirmed in Tables 2-3 The VIFs measured directly from the imaging data exhibited small (< 20%) standard deviations from the average VIF and is below the range previously reported in rats (11) and within the range observed in other studies (19, 27 The motivation of using a population-averaged over an individual VIF is the potential for high spatial resolution images to characterize tumor heterogeneity. Initially, high temporal resolution images are still needed to generate the VIF pop , but future experiments using the resulting population based VIF benefit by the decrease in required temporal resolution and the increases in spatial resolution, and/or SNR, and/or FOV.
Investigating tumor properties as a whole through ROI analysis, however, is a useful tool to capture overall tumor properties and can be used clinically to, for example, grade gliomas using extracted K trans values (41 Although using a population-averaged VIF may allow improved characterization of the tumor environment by reducing the temporal resolution and FOV constraints, it may not capture physiological differences between animals due to their disease progression. In other studies experimental or physiological variation between animals was shown to effect VIF pop estimates of model parameters (2626,29). However, assuming that experimental procedures remained consistent between animals, physiological variation did not seem to affect the degree to which VIF pop estimated parameters agree with VIF ind parameters.
To summarize, individual VIFs in eight rats were collected using an interleaved DCE-MRI procedure following an injection with Gd-DTPA. Using both the standard and extended models, pharmacokinetic parameters were extracted from fits using an individual VIF as well as the average of the individual VIFs (i.e., the population based VIF). The parameters estimated from the individual and population-averaged VIF based analyses were then compared. The results of this study indicate that both K trans and v e estimated using a population based VIF have a high level of agreement those estimated using an individual VIF. Thus, the use of a stringent injection protocol, ideally an automated syringe pump, we propose that individual vascular input functions can be obtained and combined to form a population vascular input function providing a suitable replacement for an individual VIF when one is not readily available.
Future Directions
The availability of measurements describing the molecular, cellular, and 
